A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topics

Published:2013-10 Issue:5 Volume:13 Page:657-661
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Neumann Peter J¹,Saret Cayla J¹

Affiliation:

1. Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Box #063, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1586/14737167.2013.838027

Reference9 articles.

1. 30 Years of Pharmaceutical Cost-Utility Analyses

2. Emerging Role of Pharmacoeconomics in the Research and Development Decision-Making Process

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preapproval Information Exchange: Perspectives of U.S. Population Health Decision Makers on Preferences for Early Engagement with Investigational Therapies;Journal of Managed Care & Specialty Pharmacy;2019-02

2. When Does FDAMA Section 114 Apply? Ten Case Studies;Value in Health;2015-07

3. HEALTH TECHNOLOGY ASSESSMENT OF MEDICINES IN GREECE: PHARMACEUTICAL INDUSTRY EXECUTIVES' VIEWS;International Journal of Technology Assessment in Health Care;2014-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP